S100A3 and acute myeloid leukemia: Interestingly, opposite effects are observed in PML-RARα+NB4 and PML-RARα−HL-60 AML cells, where S100A3 knockdown increases the ATRA-dependent anti-proliferative and differentiating responses, despite down-regulation of RARα.